ArticleCell death & disease2025

Enhancing immunotherapy efficacy in colorectal cancer: targeting the FGR-AKT-SP1-DKK1 axis with DCC-2036 (Rebastinib).

Xiguang Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.